[EN] 5-SUBSTITUTED ARYLPYRIMIDINES<br/>[FR] ARYLPYRIMIDINES SUBSTITUEES EN POSITION 5
申请人:NEUROGEN CORP
公开号:WO2001068614A2
公开(公告)日:2001-09-20
Arylpyrimidine compounds are provided that can act as selective modulators of CRF receptors. These compounds are useful in the treatment of a number of CNS and peripheral disorders, particularly stress, anxiety, depression, cardiovascular disorders, and eating disorders. Methods of treatment of such disorders and well as packaged pharmaceutical compositions are also provided. Compounds of the invention are also useful as probes for the localization of CRF receptors and as standards in assays for CRF receptor binding. Methods of using the compounds in receptor localization studies are given.